ROR1 and neoplasm: In patient populations with high DLEU2, lncRNA-driven ROR1 expression increased tumor proliferation and chemoresistance, dysregulated cell cycle progression and apoptosis, as well as enhanced metastatic characteristics and sphere formation [50].